Kistler-Tiffany Companies, LLC - ZYNERBA PHARMACEUTICALS INC ownership

ZYNERBA PHARMACEUTICALS INC's ticker is ZYNE and the CUSIP is 98986X109. A total of 70 filers reported holding ZYNERBA PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is 0.44 and the average weighting 0.0%.

Quarter-by-quarter ownership
Kistler-Tiffany Companies, LLC ownership history of ZYNERBA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$33
-23.3%
1000.0%0.00%
Q1 2023$43
-18.9%
1000.0%0.00%
Q4 2022$531000.0%0.00%
Q3 2022$01000.0%0.00%
Q2 2022$01000.0%0.00%
Q1 2022$01000.0%0.00%
Q4 2021$01000.0%0.00%
Q3 2021$0
-100.0%
1000.0%0.00%
Q2 2021$1,0001000.0%0.00%
Q1 2021$01000.0%0.00%
Q4 2020$01000.0%0.00%
Q3 2020$01000.0%0.00%
Q2 2020$0
-100.0%
1000.0%0.00%
Q1 2020$1,0000.0%1000.0%0.00%
Q4 2019$1,0000.0%1000.0%0.00%
Q3 2019$1,0000.0%1000.0%0.00%
Q2 2019$1,0000.0%1000.0%0.00%
Q1 2019$1,0001000.0%0.00%
Q4 2018$0
-100.0%
1000.0%0.00%
Q3 2018$1,0000.0%1000.0%0.00%
Q2 2018$1,0000.0%1000.0%0.00%
Q1 2018$1,0000.0%1000.0%0.00%
Q4 2017$1,0000.0%1000.0%0.00%
Q3 2017$1,000
-50.0%
1000.0%0.00%
-100.0%
Q2 2017$2,0000.0%1000.0%0.00%0.0%
Q1 2017$2,0001000.00%
Other shareholders
ZYNERBA PHARMACEUTICALS INC shareholders Q3 2017
NameSharesValueWeighting ↓
AdvisorShares Investments LLC 610,045$2,014,0000.47%
ETF MANAGERS GROUP, LLC 1,814,328$5,987,0000.13%
IQ EQ FUND MANAGEMENT (IRELAND) Ltd 72,169$238,0000.06%
Bernardo Wealth Planning LLC 27,219$89,0000.03%
Affinity Asset Advisors, LLC 13,285$44,0000.02%
ALGERT GLOBAL LLC 20,778$69,0000.02%
ZEKE CAPITAL ADVISORS, LLC 49,700$164,0000.01%
Founders Capital Management 2,000$18,0000.01%
King Wealth Management Group 16,000$53,0000.01%
Penserra Capital Management LLC 129,252$425,0000.01%
View complete list of ZYNERBA PHARMACEUTICALS INC shareholders